Roche Launches New Trial to Bring DMD Therapy to Europe

Pharmaceutical company Roche announced a new clinical trial that could bring a life-changing gene therapy for Duchenne muscular dystrophy to young patients across Europe.

The move comes after extensive feedback from families and regulators who want to see this treatment option become available.